Search research articles
Contact Us
Filters
Showing results (281-290 of 345) with videos related to
Page
of 35
Sort By:
Neuromuscular Disorders : NMD
|
April 3, 2018
Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands
B C Stunnenberg, J Raaphorst, J C W Deenen, et al.
Plos One
|
March 21, 2015
Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study
Anouk N A van der Horst-Schrivers, Wim J Sluiter, Anneke C Muller Kobold, et al.
The Netherlands Journal of Medicine
|
August 31, 2016
Risk stratification for healthcare planning in women with gestational diabetes mellitus
S H Koning, K A Scheuneman, H L Lutgers, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 20, 2015
Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma
Esther N Klein Hesselink, Joop D Lefrandt, Edwin P Schuurmans, et al.
Head & Neck
|
July 25, 2023
European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules: A clinical utility study in the Netherlands
Ivona Lončar, Evert F S van Velsen, Elske T Massolt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 23, 2017
Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer
Esther N Klein Hesselink, Carles Zafon, Núria Villalmanzo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 3, 2014
Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
Sophie J van Asselt, Sjoukje F Oosting, Adrienne H Brouwers, et al.
Clinical Biochemistry
|
March 1, 2017
NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk
Esther N Klein Hesselink, Anouk N A van der Horst-Schrivers, Iwan C C van der Horst, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 22, 2016
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial
Tatiana C Schneider, Djoeke de Wit, Thera P Links, et al.
Neuroendocrinology
|
November 27, 2008
Sexual function in patients with metastatic midgut carcinoid tumours
Anouk N A van der Horst-Schrivers, Ellen van Ieperen, A N Machteld Wymenga, et al.
Page
of 35
Search research articles
Search
Showing results (281-290 of 345) with videos related to
Sort By:
Page
of 35
Neuromuscular Disorders : NMD
|
April 3, 2018
Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands
B C Stunnenberg, J Raaphorst, J C W Deenen, et al.
Plos One
|
March 21, 2015
Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study
Anouk N A van der Horst-Schrivers, Wim J Sluiter, Anneke C Muller Kobold, et al.
The Netherlands Journal of Medicine
|
August 31, 2016
Risk stratification for healthcare planning in women with gestational diabetes mellitus
S H Koning, K A Scheuneman, H L Lutgers, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 20, 2015
Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma
Esther N Klein Hesselink, Joop D Lefrandt, Edwin P Schuurmans, et al.
Head & Neck
|
July 25, 2023
European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules: A clinical utility study in the Netherlands
Ivona Lončar, Evert F S van Velsen, Elske T Massolt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 23, 2017
Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer
Esther N Klein Hesselink, Carles Zafon, Núria Villalmanzo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 3, 2014
Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
Sophie J van Asselt, Sjoukje F Oosting, Adrienne H Brouwers, et al.
Clinical Biochemistry
|
March 1, 2017
NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk
Esther N Klein Hesselink, Anouk N A van der Horst-Schrivers, Iwan C C van der Horst, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 22, 2016
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial
Tatiana C Schneider, Djoeke de Wit, Thera P Links, et al.
Neuroendocrinology
|
November 27, 2008
Sexual function in patients with metastatic midgut carcinoid tumours
Anouk N A van der Horst-Schrivers, Ellen van Ieperen, A N Machteld Wymenga, et al.
Page
of 35